Commission Implementing Regulation (EU) 2020/1147 of 31 July 2020 granting a Union authorisation for the single biocidal product ‘ClearKlens product based on IPA’ (Text with EEA relevance)
Commission Implementing Regulation (EU) 2020/1147of 31 July 2020granting a Union authorisation for the single biocidal product ClearKlens product based on IPA(Text with EEA relevance)THE EUROPEAN COMMISSION,Having regard to the Treaty on the Functioning of the European Union,Having regard to Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012 concerning the making available on the market and use of biocidal productsOJ L 167, 27.6.2012, p. 1., and in particular the first subparagraph of Article 44(5) thereof,Whereas:(1)On 26 May 2016, Diversey Europe Operations B.V. submitted an application in accordance with Article 43(1) of Regulation (EU) No 528/2012 for authorisation of a single biocidal product named "ClearKlens product based on IPA" of product-type 2, as described in Annex V to that Regulation, providing written confirmation that the competent authority of the Netherlands had agreed to evaluate the application. The application was recorded under case number BC-HD024462-61 in the Register for Biocidal Products.(2)"ClearKlens product based on IPA" contains propan-2-ol, as the active substance, which is included in the Union list of approved active substances referred to in Article 9(2) of Regulation (EU) No 528/2012.(3)On 3 June 2019, the evaluating competent authority submitted, in accordance with Article 44(1) of Regulation (EU) No 528/2012, an assessment report and the conclusions of its evaluation to the European Chemicals Agency ("the Agency").(4)On 17 January 2020, the Agency submitted to the Commission an opinionECHA opinion of 11 December 2019 on the Union authorisation of "ClearKlens product based on IPA" (ECHA/BPC/236/2019)., the draft summary of the biocidal product characteristics ("SPC") of "ClearKlens product based on IPA" and the final assessment report on the single biocidal product in accordance with Article 44(3) of Regulation (EU) No 528/2012.(5)The opinion concludes that "ClearKlens product based on IPA" is a "single biocidal product" within the meaning of Article 3(1)(r) of Regulation (EU) No 528/2012, that it is eligible for Union authorisation in accordance with Article 42(1) of that Regulation and that subject to compliance with the draft SPC, it meets the conditions laid down in Article 19(1) of that Regulation.(6)On 3 February 2020, the Agency transmitted to the Commission the draft SPC in all the official languages of the Union in accordance with Article 44(4) of Regulation (EU) No 528/2012.(7)The Commission concurs with the opinion of the Agency and considers it therefore appropriate to grant a Union authorisation for "ClearKlens product based on IPA".(8)The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Biocidal Products,HAS ADOPTED THIS REGULATION: